Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Laufer

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Family Practice|October 25, 2001
Pneumonia vaccineF J Malinoski, D S Laufer
Die Pharmazie|June 13, 2001
Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenaseF Bracher, J Krauss, S Laufer
The Gerontologist|December 1, 1982
From geriatric resident to language professor: a new program using the talents of the elderly in a skilled nursing facilityE A Laufer, W S Laufer
Archiv Der Pharmazie|September 1, 1990
[Hypertensive acting 5-(beta-aminoethyl)aminoisoxazoles: synthesis and screening of derivatives with with partially rigid C-5 side chains and omega-position heterocyclics]G Dannhardt, P Dominiak, S Laufer
Osteoarthritis and Cartilage|December 5, 2002
An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugsS Laufer, C Greim, T Bertsche
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 15, 2002
The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2S Tries, W Neupert, S Laufer
Clinical Chemistry|December 1, 1988
HPLC determination of etofenamate and flufenamic acid in biological materialG Dannhardt, S Laufer, M Lehr
Pediatric Clinics of North America|June 1, 1995
Resistance to antiviralsD S Laufer, S E Starr
Journal of the American Chemical Society|February 28, 2002
Diazo group electrophilicity in kinamycins and lomaiviticin A: potential insights into the molecular mechanism of antibacterial and antitumor activityRadoslaw S Laufer, Gary I Dmitrienko
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 29, 1999
Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitorsS Laufer, P Zechmeister, T Klein
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Family Practice|October 25, 2001
Pneumonia vaccineF J Malinoski, D S Laufer
Die Pharmazie|June 13, 2001
Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenaseF Bracher, J Krauss, S Laufer
The Gerontologist|December 1, 1982
From geriatric resident to language professor: a new program using the talents of the elderly in a skilled nursing facilityE A Laufer, W S Laufer
Archiv Der Pharmazie|September 1, 1990
[Hypertensive acting 5-(beta-aminoethyl)aminoisoxazoles: synthesis and screening of derivatives with with partially rigid C-5 side chains and omega-position heterocyclics]G Dannhardt, P Dominiak, S Laufer
Osteoarthritis and Cartilage|December 5, 2002
An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugsS Laufer, C Greim, T Bertsche
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 15, 2002
The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2S Tries, W Neupert, S Laufer
Clinical Chemistry|December 1, 1988
HPLC determination of etofenamate and flufenamic acid in biological materialG Dannhardt, S Laufer, M Lehr
Pediatric Clinics of North America|June 1, 1995
Resistance to antiviralsD S Laufer, S E Starr
Journal of the American Chemical Society|February 28, 2002
Diazo group electrophilicity in kinamycins and lomaiviticin A: potential insights into the molecular mechanism of antibacterial and antitumor activityRadoslaw S Laufer, Gary I Dmitrienko
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 29, 1999
Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitorsS Laufer, P Zechmeister, T Klein
Pageof 13